2 days ago
Study Finds Cancer Target May Help Reduce Nerve Pain
Scientists found that a protein called BRAF may help send unusual pain signals.
Blocking this protein might reduce some long-lasting nerve pain.
BRAF is already used as a target in some cancer treatments.
This means researchers may have existing medicines to study.
However, the research so far has only been done before testing in people.
Cancer patients should not take BRAF inhibitors for pain on their own.
These medicines can have side effects and are approved for specific uses.
Researchers must test the idea in humans to learn whether it works safely.
If the results are confirmed, it could become another option for people with difficult-to-treat nerve pain.
Preclinical research suggests blocking the BRAF protein may reduce abnormal pain signalling.
BRAF is already an established target for cancer treatment.
Existing BRAF inhibitors could be examined in future studies of chronic nerve pain.
The findings do not mean cancer patients should take BRAF inhibitors for pain.
Human studies are needed to determine whether the approach is safe and effective.
- Who
- Researchers studying chronic nerve pain and BRAF-related treatment.
- What
- Preclinical research found that blocking BRAF may reduce abnormal nerve-pain signalling.
- Where
- When
- Why
- To explore a possible new treatment for chronic nerve pain that is difficult to control with existing therapies.
Potential treatment opportunity
Need for clinical caution
Possible new pain strategy
Potential treatment opportunity
Blocking BRAF could eventually help people whose nerve pain remains difficult to control with existing therapies.
Need for clinical caution
The effect has only been shown in preclinical research, so it is not yet known whether the approach will work reliably in people.
Use of existing medicines
Potential treatment opportunity
Because BRAF is an established cancer target, existing BRAF inhibitors could provide a starting point for future studies.
Need for clinical caution
BRAF inhibitors have specific indications, side effects and treatment considerations, and should not currently be used for pain.
Key facts
- Protein studied
- BRAF
- Research stage
- Preclinical research
- Potential treatment
- BRAF inhibitors
- Possible use
- Reducing chronic nerve pain
- Current status
- Human safety and effectiveness have not yet been established
- Warning
- BRAF inhibitors should not currently be taken for pain
Sources
Related news
Scientists discover brain 'brake' for chronic pain
Sildenafil Shows Promise Against Cancer Spread; Human Trials Still Needed
Researchers Identify Brain Circuit Behind Chemotherapy-Induced Cold Pain
India’s Smart Cancer Drug RK-251 Targets Tumor Cells
